Free AccessNeuromodulation treatments for ADHD: The ABCs of eTNSSandra Loo and James McGoughSandra LooSearch for more papers by this author and James McGough1 Professor in Residence in the Division of Child and Adolescent Psychiatry and the Center for Neurobehavioral Genetics at the Semel Institute for Neuroscience and Human Behavior in Los Angeles, CA. She also serves on the Advisory Board of the ADHD Report. She can be reached at: [email protected].2 Professor of Clinical Psychiatry at the Semel Institute for Neuroscience and Human Behavior and David Geffen School of Medicine at UCLA in Los Angeles, CA. Neither of the principal investigators (James McGough, M.D. or Sandra Loo, Ph.D.) have any financial stake or financial relationship in the product or company.Search for more papers by this authorPublished Online:February 2020https://doi.org/10.1521/adhd.2020.28.1.8PDFPDF PLUS ShareShare onFacebookTwitterLinkedInRedditEmail ToolsAdd to favoritesDownload CitationsTrack Citations AboutREFERENCESCook I. A., , Espinoza R., , Leuchter A. F. (2014). Neuromodulation for depression: Invasive andnoninvasive (deep brain stimulation, transcranial magnetic stimulation, trigeminal nervestimulation). Neurosurgery Clinics of North America; 25, 103–116. Crossref, Google ScholarFaraone S. V. (2009). Using meta-analysis to compare the efficacy of medications for Attention-Deficit/Hyperactivity Disorder in youths. Pharmacy and Therapeutics, 34(12), 678–683, 694. Google ScholarFood and Drug Administration. (2019, April 19). FDA permits marketing of first medical device for treatment of ADHD [Press release]. Retrieved from https://www.fda.gov/news-events/press-announcements/fda-permits-marketing-first-medical-device-treatment-adhd Google ScholarGoode A. P., , Coeytaux R., , Maslow G., , Davis N., , Hill S., , Namdari B., , & Kemper A. (2018). Nonpharmacologic treatments for Attention-Deficit/Hyperactivity Disorder: A systematic review. Pediatrics, 141(6), e20180094. Crossref, Google ScholarHuster R. J., , Enriquez-Geppert S., , Lavalle C. F., , Falkenstein M., , & Herrmann C. S. (2013). Electroencephalography of response inhibition tasks: functional networks and cognitive contributions. International Journal of Psychophysiology, 87, 217–233. Crossref, Google ScholarLoo S. K., , & McGough J. J. (October, 2019). Trigeminal nerve stimulation for ADHD: Correlates and predictors of treatment response. Paper presented at the American Academy of Child and Adolescent Psychiatry meeting, Chicago, IL. Google ScholarMercante B., , Enrico P., , Floris G., , Quartu M., , Boi M., , Pina Serra M., … & Deriu F. (2017). Trigeminal nerve stimulation induces FOS immunoreactivity in selected brain regions, increased hippocampal cell proliferation and reduces seizure severity in rats. Neuroscience, 361, 69–80. Crossref, Google ScholarMcGough J. J., , Loo S. K., , Sturm A., , Cowen J., , Leuchter A. F., , & Cook I. A. (2015), An eight-week, open-trial, pilot feasibility study of trigeminal nerve stimulant in youth with Attention-Deficit/Hyperactivity Disorder. Brain Stimulation; 8, 299–304. Crossref, Google ScholarMcGough J. J., , Sugar C., , Sturm A., , Salgari G., , Cowen J., , Leuchter A. F., , Cook I. A., , & Loo S. K., (2019). Double-blind, sham-controlled, pilot study of trigeminal nerve stimulation (TNS) for Attention-Deficit/Hyperactivity Disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 58(4), 403–411 Crossref, Google Scholar Previous article Next article FiguresReferencesRelatedDetails Volume 28Issue 1Feb 2020 Information© 2020 The Guilford PressPDF download